Future Cardiology logo Future Medicine logo

Future Cardiology reflects the new era of cardiology and highlights new molecular approaches in advancing cardiovascular therapy. The journal publishes clinical research, commentary and therapeutic overviews highlighting optimal therapy and future options and strategies.

Publisher: Future Medicine

Volume 1, Number 4, July 2005
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Percutaneous valve procedures – a surgeon’s viewpoint
pp. 419-420(2)
Author: Savage, Edward B

Bulletin Board

Complement component may predict the development of future cardiac events
pp. 421-423(3)

Drug Evaluation

Ambrisentan for pulmonary arterial hypertension
pp. 425-432(8)
Authors: Rubin, Lewis J; Dufton, Christopher; Gerber, Michael J

Losartan in cardiovascular disease
pp. 433-446(14)
Authors: de Vogel, Sanne; Hoorn, Ewout J; Papademetriou, Vasilios

Ranolazine, a new antianginal drug
pp. 447-455(9)
Author: Tavazzi, Luigi

Priority Paper Evaluation

Postconditioning inhibits mitochondrial permeability transition
pp. 457-460(4)
Authors: Meier, J-M; Urban, P; Goy, J-J

Clinical Trial Evaluation

Anticipating the evolution of clinical cholesterol guidelines: implications of recent statin intervention trials
pp. 461-471(11)
Authors: Meyers, Charles Daniel; Wong, Nathan; Kashyap, Moti L

Perspective

The evolving role of rescue therapy for acute myocardial infarction
pp. 473-478(6)
Authors: Tadros, George M; Iliadis, Elias A; Wilson, Robert F; Henry, Timothy D

Review

The role of insulin-like growth factor during a postischemic period – new insights into pathophysiologic pathways in cardiac tissue
pp. 479-488(10)
Authors: Palmen, Meindert; Twickler, Marcel T; Daemen, Mat J; Cramer, Maarten Jan; Doevendans, Pieter A

Cardiac markers in acute coronary syndrome
pp. 489-494(6)
Author: McCord, James K

PAPP-A: a marker of plaque instability. Is it ready for prime time?
pp. 495-500(6)
Author: Laterza, Omar F

Endothelial function and early atherosclerotic changes
pp. 501-508(8)
Authors: Okumura, Kenji; Imamura, Akiko; Murakami, Ryuichiro; Numaguchi, Yasushi; Matsui, Hideo; Toyoaki, Murohara

Lipoprotein(a) as a cardiovascular risk factor
pp. 509-517(9)
Authors: Katsouras, Christos S; Tsironis, Loukas D; Elisaf, Moses; Goodevenos, John A; Michalis, Lampros K; Tselepis, Alexandros D

Sodium–calcium exchange inhibitors: therapeutic potential in cardiovascular diseases
pp. 519-529(11)
Author: Iwamoto, Takahiro

Ryanodine receptor dysfunction in arrhythmia and sudden cardiac death
pp. 531-541(11)
Authors: George, Christopher H; Thomas, N Lowri; Lai, F Anthony

Regulation of myocardial SERCA2a expression in ventricular hypertrophy and heart failure
pp. 543-553(11)
Authors: Muller, Alice; Simonides, Warner S

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A